Therefore, addressing the effect of SMN levels and the phenotypic effects of SMN deficiency/restoration in adult mice should contribute to the understanding of SMA pathogenesis and to the development of targeted therapies. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.